Savvy Updates, 1/27/25: Insulin Costs Drop, Omnipod Dash Travel Alert, FDA At-a-Glance Nutrition Info, Modulim & Amputation Research, FTC’s Ultimatum to CVS Health, ADA & Xeris on Hypoglycemia Education, Turmeric & Diabetes, Why US Healthcare is Broken
In this week’s issue of The Savvy Diabetic: Insulin Costs Drop Omnipod Dash Travel Alert FDA At-a-Glance Nutrition Info Modulim & Amputation Research FTC’s Ultimatum to CVS Health ADA & Xeris on Hypoglycemia Education Turmeric & Diabetes...
Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?
LOTS to READ in this week’s issue of The Savvy Diabetic: Glucagon Prescriptions are UP … BUT Fall Short of Meeting Demand Special Gut Bacterium Could Help Cut Sugar Cravings FDA bans controversial red dye Processed Red Meat Increases Dementia Risk...
Savvy Updates, 12/30/24: Abbott/Dexcom Reach CGM Agreement, Endocrinologist 5th Lowest on Physician Pay Scale, Happy New Year 2025!
Abbott, Dexcom settle global CGM patent litigation by Sean Whooley for DrugDeliveryBsuiness.com, 23 December 2024. Abbott announced that it reached an agreement with Dexcom to settle all outstanding patent disputes between companies. The patent litigation relates...
Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG was announced by AccessWire.com, 19 December 2024. Modular Medical, Inc., an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs...
Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes
Insulet awarded $452M in EOFlow patent fight by Elise Reuter for MedTechDive.com, 5 December 2024. Insulet sued EOFlow and three former executives who joined the South Korea-based patch-pump maker, claiming the company “launched a plan to brazenly copy Insulet’s...
More Diabetes Blogs